Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Censoring Survival Data01:09

Censoring Survival Data

453
Survival analysis is a statistical method used to analyze time-to-event data, often employed in fields such as medicine, engineering, and social sciences. One of the key challenges in survival analysis is dealing with incomplete data, a phenomenon known as "censoring." Censoring occurs when the event of interest (such as death, relapse, or system failure) has not occurred for some individuals by the end of the study period or is otherwise unobservable, and it might have many different...
453
Parametric Survival Analysis: Weibull and Exponential Methods01:14

Parametric Survival Analysis: Weibull and Exponential Methods

922
Parametric survival analysis models survival data by assuming a specific probability distribution for the time until an event occurs. The Weibull and exponential distributions are two of the most commonly used methods in this context, due to their versatility and relatively straightforward application.
Weibull Distribution
The Weibull distribution is a flexible model used in parametric survival analysis. It can handle both increasing and decreasing hazard rates, depending on its shape parameter...
922
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

491
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
491
Introduction To Survival Analysis01:18

Introduction To Survival Analysis

657
Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
657
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

489
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
489
Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

322
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
322

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Acromegaly presenting with normal insulin-like growth factor-1 levels in a patient with advanced liver cirrhosis.

BMJ case reports·2026
Same author

Fontan-Associated Liver Disease: Trends Over Time and Relationship With Outcomes.

Journal of the American Heart Association·2025
Same author

Determinants of Intravenous Infusion Longevity and Infusion Failure via a Nonlinear Model Analysis of Smart Pump Event Logs: Retrospective Study.

JMIR AI·2024
Same author

Integrating Pre-test Probability and Point-of-Care Ultrasound (POCUS) in the Emergency Department (ED) Diagnosis of Small Bowel Obstruction (SBO).

Cureus·2024
Same author

Penalized variable selection in multi-parameter regression survival modeling.

Statistical methods in medical research·2023
Same author

Survival with primary lung cancer in Northern Ireland: 1991-1992.

Irish journal of medical science·2023
Same journal

Predictor-Assisted Nonparametric Graphical Models With Multivariate Error-Prone Data.

Statistics in medicine·2026
Same journal

Optimizing Treatment Decision Estimation for Right-Censored Survival Data Through Parameter Transfer Learning.

Statistics in medicine·2026
Same journal

Latent Class Log-Linear Models for Estimating Diagnostic Test Accuracy Without a Gold Standard: A Simulation Study.

Statistics in medicine·2026
Same journal

Interpretable Bayesian Modeling for Multireader Multicase Studies: Addressing Overdispersion and Limited Sample Size in Diagnostic Enhancement Evaluation.

Statistics in medicine·2026
Same journal

Adaptive Sequential Multiple Hypotheses Testing for Concomitant Vaccine Safety Surveillance.

Statistics in medicine·2026
Same journal

Novel Distance Regression for Repeated Outcomes With Missing Data: Applications to Longitudinal and Crossover Studies of Microbiome Beta-Diversity.

Statistics in medicine·2026
See all related articles

Related Experiment Video

Updated: Dec 23, 2025

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.7K

A multiparameter regression model for interval-censored survival data.

Defen Peng1, Gilbert MacKenzie2,3, Kevin Burke3

  • 1BC Centre for ICVHealth, Department of Medicine, The University of British Columbia, Vancouver, British Columbia, Canada.

Statistics in Medicine
|April 25, 2020
PubMed
Summary
This summary is machine-generated.

We developed flexible multiparameter regression (MPR) survival models for interval-censored data. These models, featuring nonproportional hazards and gamma frailty, offer computational efficiency and an excellent fit for clinical trial analysis.

Keywords:
crossing hazardsdispersion modelgamma frailtyinterval censoringlongitudinal studiesmultiparameter regression survival modelsnonproportional hazards Weibull

More Related Videos

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.4K
Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
05:16

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure

Published on: June 10, 2025

466

Related Experiment Videos

Last Updated: Dec 23, 2025

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.7K
An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.4K
Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
05:16

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure

Published on: June 10, 2025

466

Area of Science:

  • Biostatistics
  • Survival Analysis
  • Longitudinal Data Analysis

Background:

  • Interval-censored survival data is common in longitudinal studies and clinical trials.
  • Existing models may not adequately capture nonproportional hazards or complex dependencies.

Purpose of the Study:

  • To develop flexible multiparameter regression (MPR) survival models for interval-censored data.
  • To extend the MPR model with gamma frailty and a dispersion model for enhanced flexibility.
  • To evaluate the performance and applicability of the proposed models.

Main Methods:

  • Development of a wholly parametric multiparameter Weibull regression survival model.
  • Formulation of the interval-censored likelihood for the MPR model.
  • Incorporation of gamma frailty and a dispersion model.
  • Evaluation through simulation studies and reanalysis of the Signal Tandmobiel study data.

Main Results:

  • The proposed MPR model with gamma frailty is computationally efficient.
  • The MPR model provides an excellent fit to interval-censored longitudinal data.
  • The models effectively handle nonproportional hazards and data complexities.

Conclusions:

  • Flexible multiparameter regression models are suitable for interval-censored survival data.
  • The inclusion of gamma frailty enhances model performance and applicability in clinical trials.
  • The developed MPR models offer a robust approach for analyzing complex longitudinal survival data.